0000912282-23-000529.txt : 20231130 0000912282-23-000529.hdr.sgml : 20231130 20231130213945 ACCESSION NUMBER: 0000912282-23-000529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231128 FILED AS OF DATE: 20231130 DATE AS OF CHANGE: 20231130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VITA NICHOLAS CENTRAL INDEX KEY: 0001907623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-56294 FILM NUMBER: 231457374 MAIL ADDRESS: STREET 1: C/O COLUMBIA CARE INC. STREET 2: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cannabist Co Holdings Inc. CENTRAL INDEX KEY: 0001776738 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] IRS NUMBER: 981488978 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125543424 MAIL ADDRESS: STREET 1: 680 FIFTH AVENUE, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Columbia Care Inc. DATE OF NAME CHANGE: 20190514 4 1 form4.xml X0508 4 2023-11-28 0001776738 Cannabist Co Holdings Inc. CBSTF 0001907623 VITA NICHOLAS C/O THE CANNABIST COMPANY HOLDINGS INC. 680 FIFTH AVENUE, 24TH FLOOR NEW YORK NY 10019 true true Chief Executive Officer false Common Shares 2023-11-28 4 S 0 50000 0.34 D 21127075 I Held by Vita Holdings LLC Common Shares 2023-11-28 4 S 0 100000 0.33 D 21027075 I Held by Vita Holdings LLC Common Shares 2023-11-29 4 S 0 50000 0.34 D 20977075 I Held by Vita Holdings LLC Common Shares 2023-11-29 4 S 0 50000 0.34 D 20927075 I Held by Vita Holdings LLC Common Shares 618950 D The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3581 = US$1.00. The sales price reported above was converted from the Canadian sales price of C$0.45 using an exchange rate of C$1.3581 = US$1.00. The sales price reported above was converted from the Canadian sales price of C$0.46 using an exchange rate of C$1.3590 = US$1.00. The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3590 = US$1.00. Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes. /s/ Nicholas Vita 2023-11-30